Action Observation and Motor Imagery Therapy in Parkinson's Disease
NCT06154356
Summary
In recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in Parkinson's disease (PD). Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron system to facilitate motor re-learning. Mirror neurons are activated during the performance of goal-directed actions, also when observing the same action and visualizing the action in the mind. The aim of this clinical trial is to test whether the application of AO and MI treatment in PD in addition to conventional rehabilitation programs has an additional effect on Balance, Functional Status and Quality of Life.
Eligibility
Inclusion Criteria: * Patients with a diagnosis of Parkinson's Disease * Hoehn and Yahr Stage 1-3 Exclusion Criteria: * Patients with cognitive dysfunction (those who cannot follow simple verbal instructions) * Patients with severe hearing problems * Patients with severe vision problems * Patients with additional musculoskeletal system pathology that will affect physical performance (such as amputation, severe joint mobility limitation, peripheral nerve damage) * Patients with uncontrolled hypertension and diabetes mellitus * Patients with a history of symptomatic lung disease (such as asthma, chronic obstructive pulmonary disease, emphysema) * Patients with a history of symptomatic cardiac disease (such as coronary artery disease, arrhythmia, heart failure)
Conditions1
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06154356